Extracellular serine controls epidermal stem cell fate and tumour initiation

Sanjeethan C. Baksh, Pavlina K. Todorova, Shiri Gur-Cohen, Brian Hurwitz, Yejing Ge, Jesse S.S. Novak, Matthew T. Tierney, June dela Cruz-Racelis, Elaine Fuchs, Lydia W.S. Finley

Research output: Contribution to journalArticlepeer-review

71 Scopus citations

Abstract

Tissue stem cells are the cell of origin for many malignancies. Metabolites regulate the balance between self-renewal and differentiation, but whether endogenous metabolic pathways or nutrient availability predispose stem cells towards transformation remains unknown. Here, we address this question in epidermal stem cells (EpdSCs), which are a cell of origin for squamous cell carcinoma. We find that oncogenic EpdSCs are serine auxotrophs whose growth and self-renewal require abundant exogenous serine. When extracellular serine is limited, EpdSCs activate de novo serine synthesis, which in turn stimulates α-ketoglutarate-dependent dioxygenases that remove the repressive histone modification H3K27me3 and activate differentiation programmes. Accordingly, serine starvation or enforced α-ketoglutarate production antagonizes squamous cell carcinoma growth. Conversely, blocking serine synthesis or repressing α-ketoglutarate-driven demethylation facilitates malignant progression. Together, these findings reveal that extracellular serine is a critical determinant of EpdSC fate and provide insight into how nutrient availability is integrated with stem cell fate decisions during tumour initiation.

Original languageEnglish (US)
Pages (from-to)779-790
Number of pages12
JournalNature cell biology
Volume22
Issue number7
DOIs
StatePublished - Jul 1 2020

ASJC Scopus subject areas

  • Cell Biology

Fingerprint

Dive into the research topics of 'Extracellular serine controls epidermal stem cell fate and tumour initiation'. Together they form a unique fingerprint.

Cite this